Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Podobne zapisy

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  od: Griffiths, G, i wsp.
  Wydane: (2009)
• Issues in data monitoring and interim analysis of trials.
  od: Grant, A, i wsp.
  Wydane: (2005)
• CANparent trial evaluation: second interim report
  od: Cullen, M, i wsp.
  Wydane: (2014)
• CANparent trial evaluation: First interim report
  od: Cullen, M, i wsp.
  Wydane: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  od: Masahide Oki, i wsp.
  Wydane: (2024-12-01)